// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Investigating the effects of interleukin-33 on rhinovirus A induced changes in asthmatic bronchial epithelial cells

Rebecca Cooper - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interleukin

MicroRNA profiling in bronchial biopsies of asthma patients

Mirjam P. Roffel - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

miR-16

Novel capsaicin challenge methodology: a new diagnostic endpoint?

Kimberley Holt - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Capsaicin

EPAC drives the anti-tussive effect of EP4 receptors on airway sensory nerves

Michael A. Wortley - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Prostaglandin

The Efficacy of Bradanicline in Refractory Chronic Cough

Yoshihiro Kanemitsu - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Bradanicline

Safety and efficacy of P2X3 antagonist BAY 1902607 in refractory chronic cough

Christian Friedrich - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Risankizumab in severe asthma: A Phase IIa, placebo-controlled study

Christopher E. Brightling - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Risankizumab

In vitro fine particle dose of drug formulation used in asthma & COPD

Lois Slator - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

Salbutamol

The effects of Nrf2 activators and oxidative stress on COPD alveolar macrophages

Jian Li - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Glucocorticoid-induced adrenal suppression and metabolic syndrome in glucocorticoid treated AECOPD patients related to different gene polymorphisms of the glucocorticoid receptor gene

Pradeesh Sivapalan - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Metabolic syndrome

Glucocorticoid

Peak inspiratory flow measured at different inhaler resistances in patients with asthma

John Haughney - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Identification of mechanism-specific biomarkers to guide development of the lung-selective inhaled pan-JAK inhibitor TD-8236

Emma Gordon - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

GM-CSF

A CADSET WP4 transcriptomic analysis of Asthma and COPD overlap

Ian M. Adcock - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Characteristics of new users of single and multiple-inhaler triple therapy for COPD in primary care in England

Kieran Rothnie - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Economic impact of delayed multiple-inhaler triple therapy initiation in COPD patients

Afisi Ismaila - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial

Laura Amanda Vallejo - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Umeclidinium

Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process

John Upham - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians

Olina Efthymiadou - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Does use of hormonal contraceptives impact on exacerbations and control in reproductive-age women with asthma? A 17-year population-based cohort study

Syed Ahmar Shah - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Late Breaking Abstract - Short-acting ß2-agonist use in asthma in Western societies

Jennifer Quint - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved